Journal Logo

Articles by Troels S. Jensen

Factors with impact on magnitude of the placebo response in randomized, controlled, cross-over trials in peripheral neuropathic pain

Gillving, Mimmi; Demant, Dyveke; Lund, Karen; More

PAIN. Post Author Corrections: June 17, 2020

Experimental manipulations of pain catastrophizing influence pain levels in patients with chronic pain and healthy volunteers

Kjøgx, Heidi; Kasch, Helge; Zachariae, Robert; More

PAIN. 157(6):1287-1296, June 2016.

Pain phenotype as a predictor for drug response in painful polyneuropathy—a retrospective analysis of data from controlled clinical trials

Holbech, Jakob V.; Bach, Flemming W.; Finnerup, Nanna B.; More

PAIN. 157(6):1305-1313, June 2016.

Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel

Ventzel, Lise; Jensen, Anders B.; Jensen, Anni R.; More

PAIN. 157(3):560-568, March 2016.

Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects

Vollert, Jan; Attal, Nadine; Baron, Ralf; More

PAIN. 157(3):750-758, March 2016.

Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies—a consensus statement by the EUROPAIN and NEUROPAIN consortia

Gierthmühlen, Janne; Enax-Krumova, Elena K.; Attal, Nadine; More

PAIN. 156(11):2203-2211, November 2015.

Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study

Demant, Dyveke T.; Lund, Karen; Finnerup, Nanna B.; More

PAIN. 156(11):2234-2244, November 2015.

Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations

van Hecke, Oliver; Kamerman, Peter R.; Attal, Nadine; More

PAIN. 156(11):2337-2353, November 2015.

Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials

Vase, Lene; Vollert, Jan; Finnerup, Nanna B.; More

PAIN. 156(9):1795-1802, September 2015.

Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial

Holbech, Jakob V.; Bach, Flemming W.; Finnerup, Nanna B.; More

PAIN. 156(5):958-966, May 2015.

Corrigendum to “Value of quantitative sensory testing in neurological and pain disorders: NEUPSIG consensus” [PAIN® 2013;154(9):1807–1819]

Backonja, Miroslav “Misha; Attal, Nadine; Baron, Ralf; More

Pain. 155(1):205, January 2014.

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

Backonja, Miroslav “Misha; Attal, Nadine; Baron, Ralf; More

Pain. 154(9):1807-1819, September 2013.

Reply to the Letter to the Editor

Haanpää, Maija; Attal, Nadine; Backonja, Miroslav; More

Pain. 152(7):1683-1684, July 2011.

NeuPSIG guidelines on neuropathic pain assessment

Haanpää, Maija; Attal, Nadine; Backonja, Miroslav; More

Pain. 152(1):14-27, January 2011.

Pharmacologic management of neuropathic pain: Evidence-based recommendations

Dworkin, Robert H.; O’Connor, Alec B.; Backonja, Miroslav; More

Pain. 132(3):237-251, December 2007.

Show: